Literature DB >> 23784625

Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996-2003.

Masako Iwanaga1, Chun-Ju Chiang, Midori Soda, Mei-Shu Lai, Ya-Wen Yang, Yasushi Miyazaki, Keitaro Matsuo, Tomohiro Matsuda, Tomotaka Sobue.   

Abstract

Few studies have investigated the incidence rate of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia (LPL/WM) in Asian populations. We assessed the incidence of LPL/WM using data from 13 population-based cancer registries in Japan and data from the Taiwan National Cancer registry. During 1996-2003, a total of 280 new cases of LPL/WM were recorded in Japan and 56 were recorded in Taiwan, with the median age at diagnosis being 73 and 67 years, respectively. The incidence of LPL/WM showed male predominance in both countries. Crude age-specific incidence rates increased sharply with age in both countries, especially in people >65 years. Age-standardized (to the World standard population) incidence rates per 100,000 person-years were 0.043 (0.071 for men and 0.023 for women) and 0.031 (0.041 for men and 0.020 for women) in Japan and Taiwan, respectively. Age-standardized (to the 2,000 US standard population) incidence rates in Japan and Taiwan were lower than rates reported in the literature for Asians living in the United State. A significant increasing trend was observed in the incidence over the period from 1996 to 2003 in Japan alone. This report suggests that both environmental and/or genetic factors may be involved in LPL/WM development.
© 2013 UICC.

Entities:  

Keywords:  Asian population; Waldenström's macroglobulinemia; age-standardized incidence rate; epidemiology; lymphoplasmacytic lymphoma

Mesh:

Year:  2013        PMID: 23784625     DOI: 10.1002/ijc.28343

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review.

Authors:  Robert A Kyle; Dirk R Larson; Ellen D McPhail; Terry M Therneau; Angela Dispenzieri; Shaji Kumar; Prashant Kapoor; James R Cerhan; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2018-04-12       Impact factor: 7.616

2.  Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan.

Authors:  Akio Saito; Atsushi Isoda; Masaru Kojima; Akihiko Yokohama; Yutaka Tsukune; Makoto Sasaki; Shigeki Ito; Akihiro Ohtsu; Michiaki Koike; Kayoko Murayama; Keiichi Moriya; Hideto Tamura; Morio Matsumoto; Hirotaka Nakahashi; Sakae Tanosaki; Tohru Sakura; Toshihide Kawamura; Tomomi Miyanaga; Naoya Nakamura; Hirokazu Murakami; Hiroshi Handa; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2017-07-07       Impact factor: 2.490

3.  External-Beam Radiotherapy Alone Management of Primary CNS Lymphoplasmacytic Lymphoma: A Vietnamese Case Report and Literature Review.

Authors:  Dang Nguyen Van; Nghia Duong Van; Quang Le Van; Tung Ngo Thanh; To Ta Van
Journal:  J Blood Med       Date:  2021-08-21

4.  Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Claire M Vajdic; Ola Landgren; Mary L McMaster; Susan L Slager; Angela Brooks-Wilson; Alex Smith; Anthony Staines; Ahmet Dogan; Stephen M Ansell; Joshua N Sampson; Lindsay M Morton; Martha S Linet
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

5.  The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma.

Authors:  Kimberley Jade Anderson; Árný Björg Ósvaldsdóttir; Birgit Atzinger; Gunnhildur Ásta Traustadóttir; Kirstine Nolling Jensen; Aðalheiður Elín Lárusdóttir; Jón Thór Bergthórsson; Ingibjörg Hardardóttir; Erna Magnúsdóttir
Journal:  Oncogene       Date:  2020-06-12       Impact factor: 9.867

6.  Primary Isolated Lymphoplasmacytic Lymphoma (LPL) of the Stomach: A Case Report.

Authors:  Hany S Attallah; Mufaddal Moonim; Paul Fields; David Wrench; Jessica Brady; N George Mikhaeel
Journal:  Am J Case Rep       Date:  2020-07-20

7.  Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study.

Authors:  Seri Jeong; Seom Gim Kong; Da Jung Kim; Sangjin Lee; Ho Sup Lee
Journal:  BMC Cancer       Date:  2020-07-03       Impact factor: 4.430

8.  Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single-center experience.

Authors:  Jihoon Kang; Jung Yong Hong; Cheolwon Suh
Journal:  Blood Res       Date:  2018-09-28

9.  Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea.

Authors:  Ho Sup Lee; Kihyun Kim; Dok Hyun Yoon; Jin Seok Kim; Soo-Mee Bang; Jeong-Ok Lee; Hyeon Seok Eom; Hyewon Lee; Inho Kim; Won Sik Lee; Sung Hwa Bae; Se Hyung Kim; Mark Hong Lee; Young Rok Do; Jae Hoon Lee; Junshik Hong; Ho-Jin Shin; Ji Hyun Lee; Yeung-Chul Mun; Chang-Ki Min
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.